Safeguard Investment Advisory Group’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$261K Sell
9,281
-715
-7% -$19K 0.07% 111
2025
Q4
$249K Buy
9,996
+443
+5% +$11.2K 0.06% 114
2025
Q3
$243K Buy
+9,553
New +$236K 0.06% 119
2025
Q2
Sell
-7,895
Closed -$200K 152
2025
Q1
$200K Buy
+7,895
New +$207K 0.05% 134
2024
Q4
Sell
-7,632
Closed -$221K 126
2024
Q3
$221K Buy
+7,632
New +$223K 0.06% 100
2024
Q2
Sell
-8,358
Closed -$232K 115
2024
Q1
$232K Sell
8,358
-1,629
-16% -$45.2K 0.08% 89
2023
Q4
$288K Buy
9,987
+371
+4% +$11.2K 0.11% 72
2023
Q3
$319K Sell
9,616
-46
-0.5% -$1.63K 0.14% 67
2023
Q2
$355K Sell
9,662
-14
-0.1% -$545 0.15% 65
2023
Q1
$395K Buy
9,676
+226
+2% +$9.76K 0.19% 63
2022
Q4
$484K Buy
9,450
+584
+7% +$28K 0.3% 48
2022
Q3
$387K Buy
8,866
+4,832
+120% +$235K 0.27% 52
2022
Q2
$208K Hold
4,034
0.13% 88
2022
Q1
$208K Sell
4,034
-467
-10% -$24.2K 0.14% 80
2021
Q4
$265K Buy
+4,501
New +$223K 0.15% 78
2021
Q1
Sell
-3,710
Closed -$136K 518
2020
Q4
$136K Buy
+3,710
New +$136K 0.12% 97

Other funds holding PFE

Safeguard Investment Advisory Group's PFE Position: Q1 2026 in Review

Safeguard Investment Advisory Group reduced its Pfizer (PFE) stake by 7.2% in Q1 2026, selling an estimated $19K and leaving 9,281 shares worth $261K. The position accounts for 0.07% of the portfolio, ranked #111.

Safeguard Investment Advisory Group first reported a position in PFE in Q4 2020 and has held it in 16 quarters since. The position peaked at $484K in Q4 2022. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Safeguard Investment Advisory Group held 9,281 shares of Pfizer worth $261K as of Q1 2026.
  • Safeguard Investment Advisory Group sold 715 Pfizer shares in Q1 2026, an estimated $19K.
  • Pfizer made up 0.07% of Safeguard Investment Advisory Group's portfolio in Q1 2026, its #111 holding.
  • Safeguard Investment Advisory Group first reported a position in Pfizer in Q4 2020 and has held it in 16 quarters since.
  • Safeguard Investment Advisory Group's Pfizer position peaked at $484K in Q4 2022.
  • 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Safeguard Investment Advisory Group's 13F filing for Q1 2026, filed 14 May 2026.